The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 1.4M | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 489K | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Buy(P) | 278K | $18.00 | $5.0M |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 355K | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 489K | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Buy(P) | 278K | $18.00 | $5.0M |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 27.3M | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 9.4M | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 6.8M | — | — |
| May 1, 2026 | SR One Capital Management, LLC | 10% Owner | Conversion(C) | 9.4M | — | — |
| May 1, 2026 | Carroll Jill | Director | Conversion(C) | 1.4M | — | — |
| May 1, 2026 | Carroll Jill | Director | Conversion(C) | 489K | — | — |
| May 1, 2026 | Carroll Jill | Director | Buy(P) | 278K | $18.00 | $5.0M |
| May 1, 2026 | Carroll Jill | Director | Conversion(C) | 27.3M | — | — |
| May 1, 2026 | Carroll Jill | Director | Conversion(C) | 9.4M | — | — |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 1.3M | — | — |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 20.5M | — | $0 |
| May 1, 2026 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 4.1M | — | $0 |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 728K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 80K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 873K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 226K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 378K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 728K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 80K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 873K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 226K | — | — |
| May 1, 2026 | FMR LLC | 10% Owner | Conversion(C) | 378K | — | — |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 3.3M | — | — |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Buy(P) | 556K | $18.00 | $10.0M |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 18.0M | — | $0 |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 2.0M | — | $0 |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 25.9M | — | $0 |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 5.6M | — | $0 |
| May 1, 2026 | Novo Holdings A/S | 10% Owner | Conversion(C) | 12.6M | — | $0 |
| Apr 30, 2026 | Lavelle Erin | Director | Grant(A) | 27K | — | $0 |
| Apr 30, 2026 | Carlson Douglas R | Chief Financial Officer | Grant(A) | 212K | — | $0 |
| Apr 29, 2026 | Turner Heather D | Director | Grant(A) | 27K | — | $0 |
| Apr 29, 2026 | Congleton Jon | Director | Grant(A) | 27K | — | $0 |
| Apr 29, 2026 | Baranowski Lyn | Chief Executive Officer, Director | Grant(A) | 501K | — | $0 |
| Apr 29, 2026 | Lazarus Howard | Chief Medical Officer | Grant(A) | 212K | — | $0 |
| Apr 29, 2026 | Haviland Kate | Director | Grant(A) | 27K | — | $0 |
| Apr 29, 2026 | Rhodes Melissa | Chief Operating Officer | Grant(A) | 212K | — | $0 |
| Apr 29, 2026 | Golden Adam H. | General Counsel | Grant(A) | 255K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).